aap Implantate AG provided earnings guidance for the fiscal year 2021. For the period, the company announced that the assuming that the COVID-19 situation eases from the second quarter onwards, the company aims to return to the growth path in the financial year 2021. The Management Board expects sales of EUR 12.0 to EUR 15.0 million, which corresponds to a significant growth rate of +29 to +61%.